Are manual therapy or booster sessions worthwhile in addition to exercise therapy for knee osteoarthritis: Economic evaluation and 2-year follow-up of a randomized controlled trial

被引:6
作者
Pryymachenko, Yana [1 ]
Wilson, Ross [1 ]
Sharma, Saurab [1 ,2 ]
Pathak, Anupa [1 ]
Abbott, J. Haxby [1 ]
机构
[1] Univ Otago, Otago Med Sch, Dept Surg Sci, Ctr Musculoskeletal Outcomes Res, POB 56, Dunedin 9054, New Zealand
[2] Kathmandu Univ, Sch Med Sci, Dept Physiotherapy, Dhulikhel, Kavre, Nepal
关键词
Osteoarthritis; Exercise therapy; Manual therapy; Randomized controlled trial; Cost-effectiveness analysis; COST-EFFECTIVENESS ANALYSIS; PHYSICAL-THERAPY; WORK LOSS; HIP; MANAGEMENT; CRITERIA; CLASSIFICATION; MULTICENTER;
D O I
10.1016/j.msksp.2021.102439
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background: Exercise therapy is known to be an effective intervention for patients with osteoarthritis, however the evidence is limited as to whether adding manual therapy or booster sessions are cost-effective strategies to extend the duration of benefits. Objective: To investigate the cost-effectiveness, at 2-year follow-up, of adding manual therapy and/or booster sessions to exercise therapy. Design: 2-by-2 factorial randomized controlled trial. Methods: Participants with knee osteoarthritis were randomly allocated (1:1:1:1) to: exercise therapy delivered in consecutive sessions within 9 weeks (control group), exercise therapy distributed over 1 year using booster sessions, exercise therapy plus manual therapy delivered within 9 weeks, and exercise therapy plus manual therapy with booster sessions. The primary outcome was incremental cost-effectiveness from health system and societal perspectives interpreted as incremental net monetary benefit (INMB). Results: Of 75 participants, 66 (88 %) were retained at 1-year and 40 (53 %) at 2-year follow-up. All three interventions were cost-effective from both the health system and societal perspectives (INMBs, at 0.5 x GDP/ capita willingness to pay (WTP) threshold: $3278 (95%CI -3244 to 9800) and $3904 (95%CI -2823 to 10,632) respectively for booster sessions; $2941 (95%CI -3686 to 9568) and $2618 (95%CI -4005 to 9241) for manual therapy; $270 (95%CI -6139 to 6679) and $404 (95%CI -6097 to 6905) for manual therapy with booster sessions). Conclusion: Manual therapy or booster sessions in addition to exercise therapy are cost-effective at 2-year followup. The evidence did not support combining both booster sessions and manual therapy in addition to exercise therapy.
引用
收藏
页数:8
相关论文
共 47 条
[31]   OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. [J].
Pham, T ;
van der Heijde, D ;
Altman, RD ;
Anderson, JJ ;
Bellamy, N ;
Hochberg, M ;
Simon, L ;
Strand, V ;
Woodworth, T ;
Dougados, M .
OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (05) :389-399
[32]  
Pharmaceutical Management Agency (Pharmac), 2015, PRESCR PHARM AN METH
[33]   Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis [J].
Pinto, Daniel ;
Robertson, M. Clare ;
Hansen, Paul ;
Abbott, J. Haxby .
BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11
[34]   Long-term effectiveness of exercise therapy in patients with Osteoarthritis of the hip or knee: a systematic review [J].
Pisters, Martijn F. ;
Veenhof, Cindy ;
Van Meeteren, Nico L. U. ;
Ostelo, Raymond W. ;
De Bakker, Dinny H. ;
Schellevis, Franicois G. ;
Dekkers, Joost .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (07) :1245-1253
[35]  
Pryymachenko Y., 2020, STUDY PROTOCOL
[36]  
Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
[37]   Missing data in clinical trials: from clinical assumptions to statistical analysis using patternmixture models [J].
Ratitch, Bohdana ;
O'Kelly, Michael ;
Tosiello, Robert .
PHARMACEUTICAL STATISTICS, 2013, 12 (06) :337-347
[38]   Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds [J].
Robinson, Lisa A. ;
Hammitt, James K. ;
Chang, Angela Y. ;
Resch, Stephen .
HEALTH POLICY AND PLANNING, 2017, 32 (01) :141-145
[39]   Labour force participation and the influence of having arthritis on financial status [J].
Schofield, Deborah J. ;
Callander, Emily J. ;
Shrestha, Rupendra N. ;
Percival, Richard ;
Kelly, Simon J. ;
Passey, Megan E. .
RHEUMATOLOGY INTERNATIONAL, 2015, 35 (07) :1175-1181
[40]   Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031 [J].
Sharif, B. ;
Garner, R. ;
Hennessy, D. ;
Sanmartin, C. ;
Flanagan, W. M. ;
Marshall, D. A. .
OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (02) :249-258